+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
Endothelin Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Endothelin Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cardiometabolic Risk Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cardiometabolic Risk Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Congenital Heart Defect - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Heart Defect - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Europe Peripheral Vascular Interventions - Pipeline Insight, 2025 - Product Thumbnail Image

Europe Peripheral Vascular Interventions - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Europe
From
PDE 10 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PDE 10 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertension - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2025 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025 - Product Thumbnail Image

Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Cardiac Insufficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Cardiac Insufficiency - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Venous Ulceration - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Venous Ulceration - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Single Ventricle Heart Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Single Ventricle Heart Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Persistant Angina Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Persistant Angina Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vascular Anomalies- Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Anomalies- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hypovolemic Shock - Pipeline Insight, 2025 - Product Thumbnail Image

Hypovolemic Shock - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Giant-Cell Arteritis - Pipeline Insight, 2025 - Product Thumbnail Image

Giant-Cell Arteritis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more